You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 296 No. 14, October 11, 2006 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Topic Collections
 •Substance Abuse/ Alcoholism
 •Drug Therapy, Other
 •Alert me on articles by topic

Pharmacotherapy and Behavioral Intervention for Alcohol Dependence—Reply

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In Reply: Drs Jonas and Chabac assert that the COMBINE Study is not broadly relevant because (1) the findings were unexpected and contradict prior studies; (2) the study had a data collection rate higher than those of previous acamprosate trials; (3) the medical management intervention was intensive and not feasible; (4) the cohort was highly selected; and (5) outcomes were unusually good in the placebo group. Drs Kiefer and Mann assert that acamprosate might have been found effective if we had selected patients who were more severely dependent or in need of medical alcohol detoxification.

We disagree that neither medication showed any substantial effect relative to placebo. Main effects in a combination trial are interpretable only within the context of interactions. The observed 2-way interaction indicates that receiving either the CBI, naltrexone, or both significantly improved outcomes relative to placebo in the context of medical management. This demonstrates that medical . . . [Full Text of this Article]

Raymond F. Anton, MD
antonr@musc.edu
Medical University of South Carolina
Charleston

William R. Miller, PhD
Center on Alcoholism, Substance Abuse and Addiction
University of New Mexico
Albuquerque

Stephanie S. O’Malley, PhD
Yale University School of Medicine
New Haven, Conn

Allen Zweben, DSW
Columbia University School of Social Work
New York, NY

James D. Hosking, PhD
Collaborative Studies Coordinating Center
University of North Carolina
Chapel Hill


RELATED ARTICLES

Pharmacotherapy and Behavioral Intervention for Alcohol Dependence
Jeffrey M. Jonas and Sylvie Chabac
JAMA. 2006;296(14):1727.
EXTRACT | FULL TEXT  

Pharmacotherapy and Behavioral Intervention for Alcohol Dependence
Falk Kiefer and Karl Mann
JAMA. 2006;296(14):1727-1728.
EXTRACT | FULL TEXT  

Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence: The COMBINE Study: A Randomized Controlled Trial
Raymond F. Anton, Stephanie S. O’Malley, Domenic A. Ciraulo, Ron A. Cisler, David Couper, Dennis M. Donovan, David R. Gastfriend, James D. Hosking, Bankole A. Johnson, Joseph S. LoCastro, Richard Longabaugh, Barbara J. Mason, Margaret E. Mattson, William R. Miller, Helen M. Pettinati, Carrie L. Randall, Robert Swift, Roger D. Weiss, Lauren D. Williams, Allen Zweben, and for the COMBINE Study Research Group
JAMA. 2006;295(17):2003-2017.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.